GLP-1 medicines have been studied for Parkinson's disease, but the results do not establish a benefit for the whole drug class. Lixisenatide showed a motor-score signal in a phase 2 trial; a larger exenatide trial reported no disease-modifying benefit. The latter publication subsequently received an expression of concern.
Two trials, two different findings
| Study | Finding |
|---|---|
| Lixisenatide, phase 2, 12 months | Motor-score changes were -0.04 with lixisenatide and +3.04 with placebo, a 3.08-point between-group difference. |
| Exenatide, phase 3, 96 weeks | The study randomized 194 people and reported no evidence of disease modification. |
The 2024 LIXIPARK publication describes the lixisenatide findings. Lower motor scores indicate less disability. A score difference over one year does not by itself establish lasting disease modification.
The exenatide publication has a later editorial notice
The 2025 exenatide phase 3 publication reported its primary outcome at 96 weeks. PubMed links a June 2026 expression of concern, PMID 42330995. Both the original findings and that later notice belong in an account of the evidence.
What this means for other GLP-1 medicines
These trials studied lixisenatide and exenatide, not semaglutide or tirzepatide. Molecule, population, follow-up period and outcome differ. Results from a Parkinson's motor-score trial cannot be transferred to a weight-loss medicine simply because both act at the GLP-1 receptor.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →The useful question for future research
The next evidence needs to show whether a particular molecule changes progression on a defined outcome, and whether that finding is replicated. An early signal and a confirmed treatment effect are different conclusions.
Can this page replace medical advice about GLP-1?
No. GLP-1 For Parkinsons is informational. A licensed clinician who knows your history should review contraindications, labs, medication fit, and dose decisions.
See your options in about 2 minutes
Take the free quiz and see what fits you. Quick, private, and no commitment to continue.
See my options →